Effects of combined therapy of imeglimin and hypolipidemic agents on metabolic parameter in patients with type 2 diabetes
Not Applicable
Recruiting
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000053539
- Lead Sponsor
- Akishima Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
eGFR: less than 45 mL/min/1.73m2
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Body weight, serum lipids, and liver function marker
- Secondary Outcome Measures
Name Time Method Hemoglobin A1c level